BG98827A - Pharmaceutical composition and method for its preparation - Google Patents

Pharmaceutical composition and method for its preparation

Info

Publication number
BG98827A
BG98827A BG98827A BG9882794A BG98827A BG 98827 A BG98827 A BG 98827A BG 98827 A BG98827 A BG 98827A BG 9882794 A BG9882794 A BG 9882794A BG 98827 A BG98827 A BG 98827A
Authority
BG
Bulgaria
Prior art keywords
pharmaceutical composition
preparation
phenyl
methyl
active ingredient
Prior art date
Application number
BG98827A
Other languages
Bulgarian (bg)
English (en)
Inventor
Kalman Magyar
Jozsef Gaal
Istvan Sziraki
Jozsef Lengyel
Anna Szabo
Katalin Marmarosi
Istvan Hermecz
Istvan Szatmari
Zoltan Toeroek
Peter Koermoeczy
Original Assignee
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. filed Critical Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Publication of BG98827A publication Critical patent/BG98827A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG98827A 1991-12-20 1994-06-02 Pharmaceutical composition and method for its preparation BG98827A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU914060A HUT63579A (en) 1991-12-20 1991-12-20 Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
PCT/HU1992/000060 WO1993012775A1 (en) 1991-12-20 1992-12-18 Pharmaceutical composition and process for the preparation thereof

Publications (1)

Publication Number Publication Date
BG98827A true BG98827A (en) 1995-06-30

Family

ID=10966728

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98827A BG98827A (en) 1991-12-20 1994-06-02 Pharmaceutical composition and method for its preparation

Country Status (27)

Country Link
US (1) US5589513A (no)
EP (1) EP0617615A1 (no)
JP (1) JPH07502730A (no)
KR (1) KR940703655A (no)
AU (1) AU677170B2 (no)
BG (1) BG98827A (no)
BR (1) BR9206950A (no)
CA (1) CA2125776A1 (no)
CZ (1) CZ147494A3 (no)
EC (1) ECSP930933A (no)
EE (1) EE03015B1 (no)
FI (1) FI942932A (no)
HU (2) HUT63579A (no)
IL (1) IL104150A (no)
LT (1) LT3119B (no)
LV (1) LV10386B (no)
MY (1) MY111055A (no)
NO (1) NO942303D0 (no)
NZ (1) NZ246384A (no)
PH (1) PH31073A (no)
PL (1) PL172048B1 (no)
RO (1) RO115785B1 (no)
RU (1) RU2125448C1 (no)
SI (1) SI9200404A (no)
SK (1) SK74494A3 (no)
WO (1) WO1993012775A1 (no)
ZA (1) ZA929883B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
DE4432610C1 (de) * 1994-09-13 1996-02-01 Knoll Ag Verfahren zur Herstellung von Selegilin-Hydrochlorid
AU723047B2 (en) 1995-02-10 2000-08-17 University Of Toronto Innovations Foundation, The Deprenyl compounds for treatment of glaucoma
JP4499208B2 (ja) * 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション 新規な光学活性アミノペンタン誘導体
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
HUP9902482A2 (hu) * 1999-07-22 2002-04-29 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. P-fluoro-selegilin alkalmazása neuroprotektív gyógyszerkészítmények előállítására
EP2053033A1 (en) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
DE102009045056A1 (de) * 2009-09-28 2011-03-31 Henkel Ag & Co. Kgaa Fleckenvorbehandlungsmittel
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
HU207282B (en) * 1984-05-31 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them
DE3764144D1 (de) * 1986-04-16 1990-09-13 Asta Pharma Ag Synergistische kombination von amantadin und selegilin.
HU207280B (en) * 1986-09-25 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them
HU197510B (en) * 1986-12-19 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
CA2037178A1 (en) * 1990-02-28 1991-08-29 Albert Walter Brzeczko Deprenyl/l-dopa/carbidopa pharmaceutical composition
GB9011767D0 (en) * 1990-05-25 1990-07-18 Britannia Pharmaceuticals Ltd Pharmaceutical compositions
US5169868A (en) * 1991-03-01 1992-12-08 University Of Saskatchewan Aliphatic propargylamines as specific mao-b inhibitors
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
US5326770A (en) * 1992-07-17 1994-07-05 The Du Pont Merck Pharmaceutical Company Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals

Also Published As

Publication number Publication date
FI942932A0 (fi) 1994-06-17
CZ147494A3 (en) 1995-01-18
LV10386A (lv) 1995-02-20
HU914060D0 (en) 1992-03-30
RO115785B1 (ro) 2000-06-30
HUT63579A (en) 1993-09-28
US5589513A (en) 1996-12-31
ECSP930933A (es) 1994-04-20
ZA929883B (en) 1994-05-16
BR9206950A (pt) 1995-11-28
PH31073A (en) 1998-02-05
CA2125776A1 (en) 1993-07-08
EE03015B1 (et) 1997-08-15
IL104150A (en) 1997-11-20
NZ246384A (en) 1996-02-27
AU3265293A (en) 1993-07-28
RU2125448C1 (ru) 1999-01-27
PL172048B1 (pl) 1997-07-31
JPH07502730A (ja) 1995-03-23
LTIP249A (en) 1994-07-15
HU211478A9 (en) 1995-11-28
SK74494A3 (en) 1995-01-12
LT3119B (en) 1994-12-27
SI9200404A (en) 1993-06-30
WO1993012775A1 (en) 1993-07-08
NO942303D0 (no) 1994-06-17
MY111055A (en) 1999-08-30
FI942932A (fi) 1994-06-17
LV10386B (en) 1995-12-20
KR940703655A (ko) 1994-12-12
AU677170B2 (en) 1997-04-17
EP0617615A1 (en) 1994-10-05
NO942303L (no) 1994-08-17

Similar Documents

Publication Publication Date Title
BG98827A (en) Pharmaceutical composition and method for its preparation
BR9712085A (pt) Inibidores de metaloprotease heterocìclicos
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
UA44254C2 (uk) Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція
FI961809A (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
NO963499L (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
EA199800357A1 (ru) Фармацевтические ангиостатические дипептидные композиции и способы их применения
ATE284690T1 (de) Antithrombotische diamine
NO894602D0 (no) Farmasoeytisk blanding inneholdende n-(3,4-dimetoksy-cinnamoyl)antranilsyre.
BR9507073A (pt) Composto processos para preparar o mesmo e para tratar uma doença no sistema nervoso central composiçao farmacêutica e uso do composto
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
NO940809D0 (no) Farmasöytisk preparat inneholdende en uricosurisk og en eksitatorisk aminosyre-antagonist
BR9713178A (pt) Inbidores espirocìclicos da metaloprotease.
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
RU94031161A (ru) Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов
ES2131373T3 (es) Composicion oftalmica para prevenir o tratar el ojo seco o una enfermedad causada por el mismo, que comprende acido 12-sulfodeshidroabietico.
EA199800721A1 (ru) Ингибитор реваскуляризации
BR0315820A (pt) Inibidores de integrase de hiv, composições farmacêuticas e métodos para a sua utilização
DK0669912T3 (da) N-(3-Piperidinylcarbonyl)-beta-alaninderivater som PAF-antagonister
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
DK1274685T3 (da) Et pyridin-N-oxid-derivat og fremgangsmåde til omdannelse deraf til farmaceutisk effektive forbindelser
ATE245447T1 (de) Inhibitor von gehirnödemen
DK0674515T3 (da) Anvendelse af carbostyrilderivater til fremstilling af et medikament til inhibering af interleukin-8
RU94031479A (ru) Новое применение производных аминокислот, способ лечения, фармацевтическая композиция